Trulieve Cannabis Corp. (TRUL.CN)
Trulieve Cannabis Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Tallahassee, FL, US. The stock last traded at $16.14, down 11.07% on the session, giving a market capitalisation of $2.74B. Its beta of 1.68 implies it has historically moved more than the broad market.
Trulieve Cannabis Corp., operating through its various subsidiaries, functions as a prominent medical cannabis company. It employs a vertically integrated model, overseeing the cultivation and in-house production of its diverse product line. These offerings are then distributed through its branded Trulieve dispensaries and a home delivery service, primarily within Florida. The company provides a wide array of products, including cannabis flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. These items are marketed under distinct brands such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One. As of March 16, 2022, Trulieve operated an extensive retail network comprising 162 dispensaries. This footprint included 113 locations in Florida, 19 affiliated dispensaries in Pennsylvania, 17 in Arizona, five in California, three in Maryland, two in Massachusetts, two in West Virginia, and one in Connecticut. Beyond retail, Trulieve Cannabis Corp. also maintains cultivation and processing facilities across Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. Originally established in 1940 as Schyan Exploration Inc./Exploration Schyan Inc., the company officially adopted the name Trulieve Cannabis Corp. in September 2018. Its corporate headquarters are situated in Quincy, Florida.
Trulieve Cannabis Corp. is most often compared with the following Healthcare names: